NCT04295629

Brief Summary

Regional anesthesia is a popular anesthetic method in patients who will undergo an inguinal hernia operation. Researchers known that pain in the operating area is a complaint that impairs the quality of life for patients in the long term after the operation. In addition to regional anesthesia, has planned to investigate the effects of applying another drug near the surgery area on pain that may develop in the long term.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 29, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 4, 2020

Completed
Last Updated

March 4, 2020

Status Verified

March 1, 2020

Enrollment Period

4 months

First QC Date

February 29, 2020

Last Update Submit

March 3, 2020

Conditions

Keywords

Inguinal herniaIlioinguinal nerve blockChronic Pain

Outcome Measures

Primary Outcomes (2)

  • acute pain scores( VAS)

    Presence of pain was interrogated in the hospital within the first 24 hours (2nd, 6th, 12th, 24th hours), Visüel Analog Scale (VAS) is between 0-10 points, 0 means no pain and 10 means incredible pain.

    24 hours

  • chronic pain scores(LANSS)

    The presence of pain that may occur in the 3rd and 6th months can be learned by contacting patients by phone. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) is a neuropathic pain scale. In LANSS follow-ups, 12 points or more were associated with neuropathic pain.

    6 months

Secondary Outcomes (3)

  • taken amount of analgesic drugs

    48 hours

  • postoperative complications

    48 hours

  • hospital stay

    48 hours

Study Arms (2)

VAS (Visüel Analog Score)

ACTIVE COMPARATOR

VAS : 0-10 points 0 means: no pain 10 means: incredible pain

Procedure: Research on the effects of Ilioinguinal Nerve Block on Chronic Pain in Patients who undergo Inguinal Hernia with Spinal AnesthesiaProcedure: Ilioinguinal nerve block

LANSS (Leeds Assessment of Neuropathic Symptoms and Signs)

ACTIVE COMPARATOR

LANSS 0-24 points \>12 points : has chronic neuropathic pain \<12 points: no chronic neuropathic pain

Procedure: Research on the effects of Ilioinguinal Nerve Block on Chronic Pain in Patients who undergo Inguinal Hernia with Spinal AnesthesiaProcedure: Ilioinguinal nerve block

Interventions

The patients underwent inguinal hernia operation randomly classified into two groups in the operating room as; Group I (n:30); spinal block (SA): All patients were given SA in sitting position and 3ml 0.5% hyperbaric bupivacaine was injected in sterile conditions with 25 G injection in L3-4, L4-5 subarachnoid space. Times when the block reached T10 level were recorded.

Also known as: Spinal Anesthesia
LANSS (Leeds Assessment of Neuropathic Symptoms and Signs)VAS (Visüel Analog Score)

Group 2 (n:30); SA in sitting position and 3ml 0.5% hyperbaric bupivacaine was injected in sterile conditions with 25 G injection in L3-4, L4-5 subarachnoid space and as a ilioinguinal block (IHNB) 10 ml 5% bupivacaine was injected to patients with peripheric nerve block injection in the reanimation unit after the surgery.

LANSS (Leeds Assessment of Neuropathic Symptoms and Signs)VAS (Visüel Analog Score)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-III
  • Age 18-65
  • Inguinal hernia operation with spinal anesthesia
  • Patients who agreed to participate in the study

You may not qualify if:

  • Mental retards and communication disorder
  • Infection at the injection site
  • Patient with a clotting disorder
  • Local anesthetic allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital

Bursa, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hernia, InguinalChronic Pain

Interventions

Anesthesia, Spinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Tugba Onur, MD

    2017-17/24

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: 60 ASA I-III patients between ages 18-65 who underwent single-sided inguinal hernia operation were randomly classified into two groups in the operating room as; Group I (n:30); spinal block (SA), Group 2 (n:30); SA and ilioinguinal block (IHNB). All patients were given SA in sitting position and 3ml 0.5% hyperbaric bupivacaine was injected in sterile conditions with 25 G injection in L3-4, L4-5 subarachnoid space. Times when the block reached T10 level were recorded. Ultrasoundguided ilioinguinal block was implemented and 10 ml 5% bupivacaine was injected to patients in group I with peripheric nerve block injection in the reanimation unit after the surgery.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle İnvestigator

Study Record Dates

First Submitted

February 29, 2020

First Posted

March 4, 2020

Study Start

April 1, 2017

Primary Completion

July 31, 2017

Study Completion

December 31, 2017

Last Updated

March 4, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations